Human papilloma virus vectors
US6399383B1 · kind B1 · utility
34Cited by
9References
40Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 27, 1998 |
| Grant date | Jun 4, 2002 |
| Priority date | — |
| Expiry date | Oct 27, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2830/60
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides human papillomavirus vectors useful in gene therapy. Such a vector contains E1 and E2 coding regions from a benign or low-risk human papillomavirus operably linked to a promoter and enhancer, and an LCR region from a human papillomavirus comprising an origin of replication including binding sites for the E1 and E2 proteins. The invention further provides methods of using such vectors in gene therapy, methods of controlling expression using a patch, and methods of using such vectors to evolve drugs for stimulation of hair growth or alteration of hair color.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.